In vitro study of the photocytotoxicity of some hypericin analogs on different cell lines

Photochemistry and Photobiology

Volumn 74, Issue 2, 2001, Pages 164-171

  Delaey, E M ^a   Obermueller R ^b   Zupko I ^a   De Vos, D ^a   Falk, H ^b   De Witte, P A M ^a,c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b JOHANNES KEPLER UNIVERSITY LINZ   (Austria)

^c Campus Gasthuisberg O+N   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTINEOPLASTIC AGENT; BUFFER; CITRIC ACID; DIBENZYLTETRAMETHYLHYPERICIN; FRINGELITE D; HEXAMETHYLHYPERICIN; HYPERICIN; HYPERICIN POLYETHYLENE GLYCOL 3; LOW DENSITY LIPOPROTEIN; METHANOL; PENTAMETHYLHYPERICIN; PHOTOSENSITIZING AGENT; SOLVENT; TETRASULFONHYPERICIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CANCER CELL CULTURE; CANCER INHIBITION; CELL MEMBRANE; CELL NUCLEUS; CELL STRAIN MCF 7; CELLULAR DISTRIBUTION; CHEMICAL MODIFICATION; CONFERENCE PAPER; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG CYTOTOXICITY; DRUG DISTRIBUTION; DRUG EFFECT; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG RETENTION; DRUG SYNTHESIS; DRUG UPTAKE; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HELA CELL; HUMAN; HUMAN CELL; HYDROPHILICITY; LIPOPHILICITY; PH; PHOTOACTIVATION; PHOTOSENSITIZATION; PHOTOTOXICITY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

BLOOD PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HELA CELLS; HUMANS; PERYLENE; PHOTOCHEMISTRY; PHOTOSENSITIZING AGENTS; PROTEIN BINDING; STRUCTURE-ACTIVITY RELATIONSHIP; SUBCELLULAR FRACTIONS; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0035437588     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1562/0031-8655(2001)074<0164:IVSOTP>2.0.CO;2     Document Type: Conference Paper

References (39)

1. Racinet, H., P. Jardon and R. Gautron (1988) Formation d'oxygène singulet photosensibilisée par l'hypericine étude cinétique en milieu micellaire non ionique. J. Chim. Phys. 85, 971-977.
2. Giese, A. C. (1980) Hypericism. Photochem. Photobiol. Rev. 5, 229-255.
3. Meruelo, D., G. Lavie and D. Lavie (1988) Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin. Proc. Natl. Acad. Sci. USA 85, 5230-5234.
4. Okpanyi, S. N., B. C. Scholl and H. G. Miltenburger (1990) Genotoxizität eines standardisierten hypericum-extraktes. Arzneim. Forsch. 40, 851-855.
5. Linde, K., G. Ramirez, C. D. Mulrow, A. Pauls, W. Weidenhammer and D. Melchart (1996) St John's wort for depression an overview and meta-analysis of randomised clinical trials. Br. Med. J. 313, 253-257.
6. Diwu, Z. (1995) Novel therapeutic and diagnostic application of hypocrellin hypericins. Photochem. Photobiol. 61, 529-539.
7. Yip, L., J. B. Hudson, E. Gruszecka-kowalik, L. H. Zalkow and G. H. Neil Towers (1996) Antiviral activity of a derivative of the photosensitive compound Hypericin. Photomedicine 3, 185-190.
8. Lavie, G., Y. Mazur, D. Lavie, A. M. Prince, D. Pascual, L. Liebes, B. Levin and D. Meruelo (1995) Hypericin as an inactivator of infectious viruses in blood components. Transfusion 35, 392-400.
9. Lavie, G., F. Valentine, B. Levin, Y. Mazur, G. Gallo, D. Lavie, D. Weiner and D. Meruelo (1989) Studies of the mechanism of action of the antiretroviral agents hypericin and pseudohypericin. Proc. Natl. Acad. Sci. USA 86, 5963-5967.
10. Vandenbogaerde, A. L., E. M. Delaey, A. M. Vantieghem, B. Himpens, W. J. Merlevede and P. A. de Witte (1998) Cytotoxicity and antiproliferative effect of hypericin and derivatives after photosensitization. Photochem. Photobiol. 67, 119-125.
11. Vandenbogaerde, A., J. Cuveele, P. Proot, B. Himpens, W. J. Merlevede and P. A. de Witte (1997) Differential cytotoxic effects induced after photosensitization by hypericin. J. Photochem. Photobiol. B: Biol. 38, 136-142.
12. Vandenbogaerde, A. L., K. R. Geboes, J. F. Cuveele, P. M. Agostinis, W. J. Merlevede and P. A. de Witte (1996) Antitumour activity of photosensitized hypericin on A431 cell xenografts. Anticancer Res. 16, 1619-1626.
13. Chen, B. and P. A. de Witte (2000) Photodynamic therapy efficacy and tissue distribution of hypericin in a mouse P388 lymphoma tumor model. Cancer Lett. 150, 111-117.
14. D'Hallewin, M. A., P. de Witte, E. Waelkens, W. Merlevede and L. Baert (2000) Fluorescence detection of flat bladder carcinoma in situ after intravesical instillation of hypericin. J. Urol. 164, 349-351.
15. Vandenbogaerde, A. L., A. Kamuhabwa, E. M. Delaey, B. Himpens, W. J. Merlevede and P. de Witte (1998) Photocytotoxic effect of pseudohypericin versus hypericin. J. Photochem. Photobiol. B: Biol. 45, 87-94.
16. Kerb, R., J. Brockmoller, B. Staffeldt, M. Ploch and I. Roots (1996) Single-dose and steady-state pharmacokinetics of hypericin and pseudohypericin. Antimicrob. Agents Chemother. 40, 2087-93.
17. Kamuhabwa, A., R. Roelandts and P. de Witte (1999) Skin photosensitization with topical hypericin in hairless mice. J. Photochem. Photobiol. B: Biol 53, 110-114.
18. Falk, H., J. Meyer and M. Oberreiter (1993) A convenient semisynthetic route to hypericin. Monatsh. Chem. 124, 339-341.
19. Falk, H., A. A. O. Sarhan, T. N. H. Tran and R. Altmann (1998) Synthesis and properties of hypericins substituted with acidic and basic residues: hypericin tetrasulfonic acid - a water soluble hypericin derivative. Monatsh. Chem. 129, 309-318.
20. Amer, A. M., H. Falk and T. N. H. Tran (1998) The dissociation and tautomerization equilibria of hypericin: alkyl protected hydroxyl derivatives. Monatsh. Chem. 129, 1237-1244.
21. Altmann, R., H. Falk and H. J. Gruber (1998) Synthesis and properties of ionophore conjugated hypericin derivatives. Monatsh. Chem. 129, 235-244.
22. Altmann, R. and H. Falk (1997) The deprotonation and protonation equilibria of a hypericin derivative in aqueous solution. Monatsh. Chem. 128, 571-583.
23. Falk, H. and E. Mayr (1995) Synthesis and properties of Fringelite D 1,3,4,6,8,10,11,13-octahydroxy-phenanthro[1,10,9,8,o, p,q,r,a]perylene-7,14-dione. Monatsh. Chem. 126, 699-710.
24. Falk, H. and G. Schoppel (1992) On the synthesis of hypericin by oxidative trimethylemodin anthrone and emodine anthrone dimerization: isohypericin. Monatsh. Chem. 123, 931-938.
25. Lin, C.-W., J. R. Shulok, K.-Y. Wong, C. F. Schanbacher, L. Cincotta and J. W. Foley (1991) Photosensitization, uptake, and retention of phenoxazine nile blue derivatives in human bladder carcinoma cells. Cancer Res. 51, 1109-1116.
26. Miller, G. G., K. Brown, R. B. Moore, Z. J. Diwu, J. Liu, L. Huang, J. W. Lown, D. A. Begg, V. Chlumecky and J. Tulip (1995) Uptake kinetics and intracellular localization of hypocrellin photosensitizers for photodynamic therapy: a confocal microscopy study. Photochem. Photobiol. 61, 632-638.
27. Sousa, C., T. Sá e Melo, M. Gèze, J.-M. Gaullier, J. C. Mazière and R. Santus (1996) Solvent polarity and pH effects on the spectroscopic properties of neutral red: application to lysosomal microenvironment probing in living cells. Photochem. Photobiol. 63, 601-607.
28. Hopkinson, H. J., D. I. Vernon and S. B. Brown (1999) Identification and partial characterization of an unusual distribution of the photosensitizer meta-tetrahydroxyphenyl chlorin (Temoporfin) in human plasma. Photochem. Photobiol. 69, 482-488.
29. Havel, R. J., H. A. Eder and J. H. Bragdon (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34, 1345-1353.
30. Kongshaug, M., J. Moan and S. B. Brown (1989) The distribution of porphyrins with different tumour localising ability among human plasma proteins. Br. J. Cancer 59, 184-188.
31. Weber, N. D., B. K. Murray, J. A. North and S. G. Wood (1994) The antiviral agent hypericin has in vitro activity against HSV-1 through non-specific association with viral and cellular membranes. Antivir. Chem. Chemother. 5, 83-90.
32. Delaey, E. M., A. Kamuhabwa, A. Vandenbogaerde and P. A. de Witte (1999) Photocytotoxicity of protohypericin after photoconversion to hypericin. Planta Med. 65, 719-722.
33. Chasar, D. W. (1977) Thin-layer chromatographic behavior of 1,8-dihydroxyanthraquinone and its methyl ethers. Chem. Ind. 1, 31-32.
34. Dougherty, T. J., C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel? M. Korbelik, J. Moan and Q. Peng (1998) Photodynamic therapy. J. Natl. Cancer Inst. 90, 889-905.
35. Kongshaug, M., J. Moan, C. Rimington and J. F. Evensen (1990) Binding of PDT photosensitizers to human plasma studied by ultracentrifugation. In Photodynamic Therapy of Neoplastic Disease, Vol. 2 (Edited by D. Kessel), pp. 43-61. CRC Press, Boston.
36. Hamblin, M. R. and E. L. Newman (1994) On the mechanism of the tumor-localising effect in photodynamic therapy. J. Photochem. Photobiol. B: Biol. 23, 3-8.
37. Roberts, W. G. and T. Hasan (1992) Role of neovasculature and vascular permeability on the tumor retention of photodynamic agents. Cancer Res. 52, 924-930.
38. Reddi, E., C. Zhou, R. Biolo, E. Menegaldo and G. Jori (1990) Liposome-or LDL-administered Zn(II)-phthalocyanine as a photodynamic agent for tumors. I. Pharmacokinetic properties and phototherapeutic efficiency. Br. J. Cancer 61, 407-411.
39. Bezdetnaya, L., N. Zeghari, I. Belitchenko, M. Barberi-Heyob, J.-L. Merlin, A. Potapenko and F. Guillemin (1996) Spectroscopic and biological testing of photobleaching of porphyrins in solutions. Photochem. Photobiol. 64, 382-386.